Skip to main content
SpringerLink
Log in

Development and Validation of RP-LC Method for the Simultaneous Determination of Simvastatin and Ezetimibe in Fixed-Dose Combination Tablets and in Rabbit Serum

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Combined drug therapy which is based on the co-administration of two or more drugs, have been used for a long time, to treat diseases. In this study, a simple, selective and rapid RP-LC method has been developed and validated for the sensitive and simultaneous determination of simvastatin (SMV) and ezetimibe (EZE) in fixed-dose combination tablets and in rabbit serum using a simple sample preparation procedure. The developed RPLC method for these lipid-lowering agents was completely validated and in the linear range of 0.05–50 µg mL− 1 EZE and 0.05–10 µg mL− 1 SMV. The calibration curves were obtained with limit of detection values of 0.013 µg mL− 1, 0.009 µg mL− 1—for EZE and SMV, respectively. The developed method was successfully applied to the analysis of EZE and SMV in fixed-dose combination tablets and in rabbit serum, and no interference was observed from any excipients and endogenous substances in the rabbit serum samples. Dissolution profiles of the pharmaceutical dosage form of these lipid-lowering agents were also studied.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Li MC, Whitmore WF, Golbey R, Grabstald H (1960) Effects of combined drug therapy on metastatic cancer of the testis. JAMA 174:1291. https://doi.org/10.1001/jama.1960.03030100059013

    Article  CAS  PubMed  Google Scholar 

  2. Casey JF, Hollister LE, Klett CJ et al (1961) Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine. Am J Psychiatry 117:997–1003. https://doi.org/10.1176/ajp.117.11.997

    Article  CAS  PubMed  Google Scholar 

  3. Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681. https://doi.org/10.1124/pr.58.3.10

    Article  CAS  PubMed  Google Scholar 

  4. Chou TC (2010) Drug combination studies and their synergy quantification using the chou-talalay method. Cancer Res 70:440–446

    Article  CAS  PubMed  Google Scholar 

  5. Goldin A, Mantel N (1957) The employment of combinations of drugs in the chemotherapy of neoplasia: a review. Cancer Res 17:635–654. https://doi.org/10.1158/0008-5472.can-09-1947

    Article  CAS  PubMed  Google Scholar 

  6. Roth A, Maibach R, Martinelli G et al (2000) Docetaxel (Taxotere®)-cisplatin (TC): an effective drug combination in gastric carcinoma. Ann Oncol 11(3):301-306 (academic.oup.com)

    Article  Google Scholar 

  7. Demirbolat G, Altintas L, Yilmaz S et al (2018) Development of orally applicable, combinatorial drug–loaded nanoparticles for the treatment of fibrosarcoma. J Pharm Sci 107(5):1398–1407

    Article  CAS  PubMed  Google Scholar 

  8. Kalra S, Kalra B, Agrawal N (2010) Combination therapy in hypertension: an update. Diabetol Metab Syndr 2:44. https://doi.org/10.1186/1758-5996-2-44

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. George F, Barbara, Speed C et al (2011) Managing hypertension using combination therapy. Am Fam Phys 83:1207–1208

    Google Scholar 

  10. Nutescu EA, Shapiro NL (2003) Ezetimibe: a selective cholesterol absorption inhibitor. Pharmacotherapy 23:1463–1474. https://doi.org/10.1592/phco.23.14.1463.31942

    Article  CAS  PubMed  Google Scholar 

  11. Dujovne CA, Ettinger MP, McNeer JF et al (2002) Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 90:1092–1097. https://doi.org/10.1016/S0002-9149(02)02798-4

    Article  CAS  PubMed  Google Scholar 

  12. Bays HE, Moore PB, Drehobl MA et al (2001) Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 23:1209–1230. https://doi.org/10.1016/S0149-2918(01)80102-8

    Article  CAS  PubMed  Google Scholar 

  13. Ballantyne CM, Houri J, Notarbartolo A et al (2003) Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 107:2409–2415. https://doi.org/10.1161/01.CIR.0000068312.21969.C8

    Article  CAS  PubMed  Google Scholar 

  14. Davidson MH, McGarry T, Bettis R et al (2002) Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 40:2125–2134. https://doi.org/10.1016/S0735-1097(02)02610-4

    Article  CAS  PubMed  Google Scholar 

  15. Kastelein JJP, Akdim F, Stroes ESG et al (2008) Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358:1431–1443. https://doi.org/10.1056/NEJMoa0800742

    Article  CAS  PubMed  Google Scholar 

  16. Naidu KR, Kale UN, Shingare MS (2005) Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J Pharm Biomed Anal 39:147–155. https://doi.org/10.1016/J.JPBA.2005.04.001

    Article  CAS  PubMed  Google Scholar 

  17. Kurbanoglu S, Gumustas M, Ozkan SA (2013) Simultaneous estimation and validation of some binary mixtures of antihypertensive drugs by RP-LC methods using two new generation silica columns. J Pharm Biomed Anal 72:198–201. https://doi.org/10.1016/J.JPBA.2012.08.018

    Article  CAS  PubMed  Google Scholar 

  18. Ozkan CK, Kurbanoglu S, Esim O et al (2016) Simultaneous determination and drug dissolution testing of combined amlodipine tablet formulations using RP-LC. Chromatographia 79:1143–1151. https://doi.org/10.1007/s10337-016-3125-x

    Article  CAS  Google Scholar 

  19. Kurbanoglu S, Gumustas M, Uslu B, Ozkan SA (2013) A sensitive and selective RP-LC method for the simultaneous determination of the antihypertensive drugs, enalapril, lercanidipine, nitrendipine and their validation. Chromatographia 76:1477–1485. https://doi.org/10.1007/s10337-013-2465-z

    Article  CAS  Google Scholar 

  20. Ashfaq M, Ullahkhan I, Qutab SS, Naeemrazzaq S (2007) HPLC determination of ezetimibe and simvastatin in pharmaceutical formulations. J Chil Chem Soc 52:1220–1223. https://doi.org/10.4067/S0717-97072007000300005

    Article  CAS  Google Scholar 

  21. Wang Y, Liang Y, Zhang J et al (2016) Simultaneous separation and determination of four main isoflavonoids in Astragali Radix by an isocratic LC/ESI-MS method. J Cent South Univ 23:303–309. https://doi.org/10.1007/s11771-016-3074-4

    Article  CAS  Google Scholar 

  22. Palabiyik IM, Onur F, Yardimci C, Özaltin N (2008) Simultaneous spectrophotometric determination of ezetimibe and simvastatin in pharmaceutical preparations using chemometric techniques. Quim Nova 31:1121–1124. https://doi.org/10.1590/s0100-40422008000500035

    Article  CAS  Google Scholar 

  23. Hefnawy M, Al-Omar M, Julkhuf S (2009) Rapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic column. J Pharm Biomed Anal 50:527–534. https://doi.org/10.1016/J.JPBA.2009.05.002

    Article  CAS  PubMed  Google Scholar 

  24. The United States Pharmacopeia (The USP 40-NF 35) (2017) The official compendia of standards. United States Pharmacopeial Convention, MD, Rockwille, USA

    Google Scholar 

  25. Michael E. Swartz ISK (1997) Analytical method development and validation. J Pharm Res 3:96

    Google Scholar 

  26. Chan CC, Lam. H, Lee YC, Zhang X-M (2004) Analytical method validation and instrument performance verification. Wiley, New York

    Book  Google Scholar 

  27. ICH Guidelines T (1995) Validation of analytical procedures, methodology international council on harmonization. Brussels, Belgium

  28. Swartz ME, Krull IS (1997) Analytical method development and validation, vol 3. Marcel Dekker, New York, p 96

    Google Scholar 

  29. Mendyk A, Jachowicz R (2007) Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst Appl 32:1124–1131. https://doi.org/10.1016/J.ESWA.2006.02.019

    Article  Google Scholar 

  30. Taupitz T, Dressman JB, Klein S (2013) New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm 84:208–218. https://doi.org/10.1016/J.EJPB.2012.11.027

    Article  CAS  PubMed  Google Scholar 

  31. Costa P, Sousa Lobo JM (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–133. https://doi.org/10.1016/S0928-0987(01)00095-1

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This paper is dedicated to Chromatographia 50th Anniversary commemorative issue.

Author information

Authors and Affiliations

  1. Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Yenimahalle, 06560, Ankara, Turkey

    Sevinc Kurbanoglu & Sibel A. Ozkan

  2. Department of Pharmaceutical Technology, Gulhane Faculty of Pharmacy, University of Health Sciences, Etlik, 06018, Ankara, Turkey

    Ozgur Esim, Cansel Kose Ozkan, Ayhan Savaser & Yalcin Ozkan

Authors
  1. Sevinc Kurbanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozgur Esim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cansel Kose Ozkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayhan Savaser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yalcin Ozkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sibel A. Ozkan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sibel A. Ozkan.

Ethics declarations

Conflict of Interest

All authors declare that he or she has no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Additional information

Published in Chromatographia’s 50th Anniversary Commemorative Issue.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Figure SI. 1

. Calibration graphs for EZE and SMV in A-C mobile phase and B-D rabbit serum (PDF 51 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurbanoglu, S., Esim, O., Ozkan, C.K. et al. Development and Validation of RP-LC Method for the Simultaneous Determination of Simvastatin and Ezetimibe in Fixed-Dose Combination Tablets and in Rabbit Serum. Chromatographia 82, 279–285 (2019). https://doi.org/10.1007/s10337-018-3642-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-018-3642-x

Keywords

Search

Navigation